Usana Health Sciences (USNA) Liabilities and Shareholders Equity (2011 - 2026)

Usana Health Sciences (USNA) has 16 years of Liabilities and Shareholders Equity data on file, last reported at $739.0 million in Q2 2026.

• On a quarterly basis, Liabilities and Shareholders Equity fell 1.02% year-over-year to $739.0 million in Q2 2026; TTM through Apr 2026 was $2.2 billion, a 21.06% decrease from a year earlier, with the FY2026 full-year figure at $742.9 million, down 0.71% from the prior year.
• Liabilities and Shareholders Equity for Q2 2026 stood at $739.0 million, down from $742.9 million in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for USNA reached as high as $748.2 million in Q4 2024 and fell as low as $556.1 million in Q4 2022.
• Historically, Liabilities and Shareholders Equity has averaged $643.4 million across 5 years, with a median of $629.3 million in 2024.
• Across the five-year window, Liabilities and Shareholders Equity decreased 9.85% in 2022 and advanced 18.64% in 2025, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $596.5 million in 2022, then grew by 6.07% to $632.8 million in 2023, then rose by 18.24% to $748.2 million in 2024, then fell by 2.89% to $726.6 million in 2025, then advanced by 1.7% to $739.0 million in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $739.0 million in Q2 2026, $742.9 million in Q1 2026, and $726.6 million in Q3 2025.